U.S. markets closed

Recro Pharma, Inc. (REPH)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.9600+0.1000 (+5.38%)
At close: 4:00PM EDT
1.9600 0.00 (0.00%)
After hours: 04:19PM EDT
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Total Revenue
61,525
66,499
99,219
77,347
71,834
Cost of Revenue
50,217
54,134
50,981
43,160
38,193
Gross Profit
11,308
12,365
48,238
34,187
33,641
Operating Expense
19,944
20,707
22,492
79,447
61,104
Operating Income
-8,636
-8,342
25,746
-45,260
-27,463
Net Non Operating Interest Income Expense
-17,934
-19,159
-19,005
-8,244
-11,649
Other Income Expense
-
-
-2,116
-8,783
-12,848
Pretax Income
-26,570
-27,501
4,625
-62,287
-51,960
Tax Provision
-
0
0
17,436
-1,880
Net Income Common Stockholders
-26,570
-27,501
-18,630
-79,723
-50,080
Diluted NI Available to Com Stockholders
-26,570
-27,501
-18,630
-79,723
-50,080
Basic EPS
-
-1.16
-0.83
-3.90
-2.63
Diluted EPS
-
-1.16
-0.83
-3.90
-2.63
Basic Average Shares
-
23,744
22,414
20,465
19,071
Diluted Average Shares
-
23,744
23,609
20,465
19,071
Total Operating Income as Reported
-8,636
-8,342
23,630
-54,043
-40,311
Total Expenses
70,161
74,841
73,473
122,607
99,297
Net Income from Continuing & Discontinued Operation
-26,570
-27,501
-18,630
-79,723
-50,080
Normalized Income
-26,570
-27,501
6,741
-73,311
-37,695
Interest Income
-
-
801
512
385
Interest Expense
17,934
19,159
19,806
8,756
12,034
Net Interest Income
-17,934
-19,159
-19,005
-8,244
-11,649
EBIT
-8,636
-8,342
24,431
-53,531
-39,926
EBITDA
-153
-
-
-
-
Reconciled Cost of Revenue
44,317
48,170
45,164
37,893
33,329
Reconciled Depreciation
8,483
8,547
8,400
7,850
7,447
Net Income from Continuing Operation Net Minority Interest
-26,570
-27,501
4,625
-79,723
-50,080
Total Unusual Items Excluding Goodwill
-
-
-2,116
-8,783
-12,848
Total Unusual Items
-
-
-2,116
-8,783
-12,848
Normalized EBITDA
-153
205
34,947
-36,898
-19,631
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
-2,371
-462.528